A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma
about
A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
A prospective, open-label, mul ...... patients with multiple myeloma
@ast
A prospective, open-label, mul ...... patients with multiple myeloma
@en
type
label
A prospective, open-label, mul ...... patients with multiple myeloma
@ast
A prospective, open-label, mul ...... patients with multiple myeloma
@en
prefLabel
A prospective, open-label, mul ...... patients with multiple myeloma
@ast
A prospective, open-label, mul ...... patients with multiple myeloma
@en
P2093
P2860
P356
P1433
P1476
A prospective, open-label, mul ...... patients with multiple myeloma
@en
P2093
Byung Soo Kim
Chang-Ki Min
Chul Won Choi
Deog Yeon Jo
Do-Yeun Cho
Ho Sup Lee
Ho-Jin Shin
Hoon-Gu Kim
Hyeon Gyu Yi
P2860
P304
37605-37618
P356
10.18632/ONCOTARGET.16790
P407
P577
2017-06-01T00:00:00Z